CatalystEarnings

HOW SUPERNUS’ Q2 BEAT AND RAISED GUIDANCE COULD RESHAPE SUPERNUS PHARMACEUTICALS (SUPN) INVESTORS’ OUTLOOK - YAHOO FINANCE - GNEWS

Q2 beat and raised guidance signal stronger outlook for Supernus Pharmaceuticals.

What changed

Q2 beat and raised guidance signal stronger outlook for Supernus Pharmaceuticals.

Why it matters

Q2 beat and raised guidance signal stronger outlook for Supernus Pharmaceuticals. — impact context not separately stored; see What changed.

Sources